Structure Therapeutics Files Q1 2025 10-Q
Ticker: GPCR · Form: 10-Q · Filed: May 8, 2025 · CIK: 1888886
| Field | Detail |
|---|---|
| Company | Structure Therapeutics Inc. (GPCR) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Structure Therapeutics (GPCR) Q1 2025 10-Q filed. Financials updated.
AI Summary
Structure Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as ShouTi Inc., is in the pharmaceutical preparations industry. Key financial data points include retained earnings, additional paid-in capital, and accumulated other comprehensive income as of March 31, 2025, and prior periods.
Why It Matters
This filing provides investors with the latest financial snapshot of Structure Therapeutics, detailing their capital structure and retained earnings as of the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- 172,610,000 — Total Assets (As of March 31, 2025)
- 171,860,000 — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- Structure Therapeutics Inc. (company) — Filer of the 10-Q
- ShouTi Inc. (company) — Former name of Structure Therapeutics Inc.
- 20250331 (date) — Reporting period end date
- 20250508 (date) — Filing date
FAQ
What is the company's primary business activity?
Structure Therapeutics Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company's name changed?
The company's name was changed from ShouTi Inc. on October 19, 2021.
What is the reporting period for this 10-Q filing?
The reporting period is for the quarter ended March 31, 2025.
What are some key financial statement components reported as of March 31, 2025?
The filing reports values for Retained Earnings, Additional Paid-In Capital, and Accumulated Other Comprehensive Income as of March 31, 2025.
What is the company's SEC file number?
The SEC file number for Structure Therapeutics Inc. is 001-41608.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Structure Therapeutics Inc. (GPCR).